Incidence of late recurrence and second primary cancers 5-10 years after non-metastatic colorectal cancer.
colorectal cancer
disease recurrence
metachronous cancer
national health care data registries
second primary cancer
Journal
International journal of cancer
ISSN: 1097-0215
Titre abrégé: Int J Cancer
Pays: United States
ID NLM: 0042124
Informations de publication
Date de publication:
07 Feb 2024
07 Feb 2024
Historique:
revised:
09
01
2024
received:
22
11
2023
accepted:
19
01
2024
medline:
7
2
2024
pubmed:
7
2
2024
entrez:
7
2
2024
Statut:
aheadofprint
Résumé
The fraction of patients who are cancer-free survivors 5 years after curative-intended surgery for colorectal cancer (CRC) is increasing, suggesting that extending surveillance beyond 5 years may be indicated. Here we estimate the incidence of late recurrence, metachronous CRC, and second primary cancers 5-10 years postoperative. All patients resected for UICC stage I-III CRC in Denmark through 2004-2013 were identified. Through individual-level linkage of nationwide health registry data, recurrence status was determined using a validated algorithm. Cancer-free survivors 5 years after surgery, were included. Cumulative incidence functions (CIF) of late recurrence, metachronous CRC, and second primary cancer 5-10 years postoperative were constructed. Subdistribution hazards ratios (sHR) were computed using Fine-Gray regression. Among 8883 patients, 370 developed late recurrence (5-10-year CIF = 4.1%, 95%CI: 3.7%-4.6%), 270 metachronous CRC (5-10-year CIF = 3.0%, 95%CI: 2.7%-3.4%), and 635 a second primary cancer (5-10-year CIF = 7.2%, 95%CI: 6.7%-7.7%). The risk of late recurrence was reduced for patients operated in 2009-2013 compared to 2004-2008 (2.9% vs. 5.6%, sHR = 0.52, 95% CI: 0.42-0.65). The risk of metachronous CRC was likewise reduced from 4.1% to 2.1% (sHR = 0.50, 95%CI: 0.39-0.65). While the risk of second primary cancer did not change between 2009-2013 and 2004-2008 (7.1% vs. 7.1%, sHR = 0.98, 95% CI: 0.84-1.15). Using nation-wide 10-year follow-up data, we document that the incidences of late recurrence and metachronous CRC are low and decreasing from 2004 to 2013. Thus, despite increasing numbers of long-term cancer survivors, the data do not advocate for extending CRC-specific surveillance beyond 5 years.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Kraeftens Bekaempelse
ID : R231-A13845 [Andersen]
Organisme : Kraeftens Bekaempelse
ID : R257-A14700 [Andersen]
Organisme : Institut for Klinisk Medicin, Aarhus Universitet (Phd scholarship [Nors])
Organisme : Novo Nordisk Fonden
ID : NNF17OC0025052 [Andersen]
Organisme : Novo Nordisk Fonden
ID : NNF22OC0074415 [Andersen]
Organisme : Innovationsfonden
ID : 9068-00046B [Andersen]
Informations de copyright
© 2024 The Authors. International Journal of Cancer published by John Wiley & Sons Ltd on behalf of UICC.
Références
Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209-249.
van Gestel YRBM, de Hingh IHJT, van Herk-Sukel MPP, et al. Patterns of metachronous metastases after curative treatment of colorectal cancer. Cancer Epidemiol. 2014;38(4):448-454.
Nors J, Iversen LH, Erichsen R, Gotschalck KA, Andersen CL. Incidence of recurrence and time to recurrence in stage I to III colorectal cancer: a nationwide Danish cohort study. JAMA Oncol. 2023;16:54-62. doi:10.1001/jamaoncol.2023.5098
Glynne-Jones R, Wyrwicz L, Tiret E, et al. Rectal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018;29(Suppl 4):iv263.
Argilés G, Tabernero J, Labianca R, et al. Localised colon cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2020;31(10):1291-1305.
Iversen LH, Green A, Ingeholm P, Østerlind K, Gögenur I. Improved survival of colorectal cancer in Denmark during 2001-2012: the efforts of several national initiatives. Acta Oncol. 2016;55(Suppl 2):10-23.
Larsen MB, Njor S, Ingeholm P, Andersen B. Effectiveness of colorectal cancer screening in detecting earlier-stage disease: a nationwide cohort study in Denmark. Gastroenterology. 2018;155(1):99-106.
Health at a Glance: Europe. State of Health in the EU Cycle. 2022.
Seo SI, Lim SB, Yoon YS, et al. Comparison of recurrence patterns between ≤5 years and >5 years after curative operations in colorectal cancer patients. J Surg Oncol. 2013;108(1):9-13.
Bouvier AM, Launoy G, Bouvier V, et al. Incidence and patterns of late recurrences in colon cancer patients. Int J Cancer. 2015;137(9):2133-2138.
Cottet V, Bouvier V, Rollot F, et al. Incidence and patterns of late recurrences in rectal cancer patients. Ann Surg Oncol. 2015;22(2):520-527. doi:10.1245/s10434-014-3990-1
von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Epidemiology. 2007;18(6):800-804.
Sørensen HT, Pedersen L, Jørgensen J, Ehrenstein V. Danish clinical quality databases: an important and untapped resource for clinical research. Clin Epidemiol. 2016;8:425-427.
Ingeholm P, Gögenur I, Iversen LH. Danish colorectal cancer group database. Clin Epidemiol. 2016;8:465-468.
Schmidt M, Schmidt SAJ, Adelborg K, et al. The Danish health care system and epidemiological research: from health care contacts to database records. Clin Epidemiol. 2019;11:563-591.
Gjerstorff ML. The Danish cancer registry. Scand J Public Health. 2011;39(7_suppl):42-45. doi:10.1177/1403494810393562
Schmidt M, Schmidt SAJ, Sandegaard JL, Ehrenstein V, Pedersen L, Sørensen HT. The Danish National Patient Registry: a review of content, data quality, and research potential. Clin Epidemiol. 2015;7:449-490.
Erichsen E. Existing data sources for clinical epidemiology: the Danish National Pathology Registry and data Bank. Clin Epidemiol. 2010;2:51-56. doi:10.2147/clep.s9908
Pedersen CB. The Danish civil registration system. Scand J Public Health. 2011;39(7 Suppl):22-25.
Lash TL, Riis AH, Ostenfeld EB, Erichsen R, Vyberg M, Thorlacius-Ussing O. A validated algorithm to ascertain colorectal cancer recurrence using registry resources in Denmark. Int J Cancer. 2015;136(9):2210-2215. doi:10.1002/ijc.29267
Nors J, Mattesen TB, Cronin-Fenton D, et al. Identifying recurrences among non-metastatic colorectal cancer patients using National Health Data Registries: validation and optimization of a registry-based algorithm in a modern Danish cohort. Clin Epidemiol. 2023;15:241-250.
Sobin LH, Fleming ID. TNM classification of malignant tumors, fifth edition (1997). Union Internationale Contre le cancer and the American joint committee on cancer. Cancer. 1997;80(9):1803-1804.
Charlson ME, Pompei P, Ales KL, Ronald MKC. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-383. doi:10.1016/0021-9681(87)90171-8
Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94(446):496-509. doi:10.1080/01621459.1999.10474144
Halamkova J, Kazda T, Pehalova L, et al. Second primary malignancies in colorectal cancer patients. Sci Rep. 2021;11(1):2759.
Liang LA, Tseng YJ, Tanaka LF, Klug SJ. Second primary cancer among 217702 colorectal cancer survivors: an analysis of national German cancer registry data. Int J Cancer. 2023;153:1459-1471. doi:10.1002/ijc.34638
van Lanschot MCJ, van Leerdam ME, Lansdorp-Vogelaar I, et al. Yield of surveillance colonoscopies 1 year after curative surgical colorectal cancer resections. Clin Gastroenterol Hepatol. 2019;17(11):2285-2293.
Rex DK, Kahi CJ, Levin B, et al. Guidelines for colonoscopy surveillance after cancer resection: a consensus update by the American Cancer Society and US multi-society task force on colorectal cancer. CA Cancer J Clin. 2006;56(3):160-167. quiz 185-186.
Meyerhardt JA, Mangu PB, Flynn PJ, et al. Follow-up care, surveillance protocol, and secondary prevention measures for survivors of colorectal cancer: American Society of Clinical Oncology clinical practice guideline endorsement. J Clin Oncol. 2013;31(35):4465-4470.
Bouvier AM, Latournerie M, Jooste V, Lepage C, Cottet V, Faivre J. The lifelong risk of metachronous colorectal cancer justifies long-term colonoscopic follow-up. Eur J Cancer. 2008;44(4):522-527.